MedPath

TRANSlational Cancer Oesophagus Gefitinib study (TRANS-COG)

Not Applicable
Completed
Conditions
Cancer
pper Gastro-Intestinal Cancer
Malignant neoplasm of oesophagus
Registration Number
ISRCTN32435732
Lead Sponsor
niversity of Aberdeen (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
300
Inclusion Criteria

1. Patients with oesophagogastric cancer must be eligible for and enrolled in the COG trial
2. Ability to provide written informed consent
3. Formalin-fixed and paraffin-embedded (FFPE) tumour material available
4. Male and female participants
5. Lower Age Limit 18 years

Exclusion Criteria

1. Patients not enrolled in COG trial
2. Inability to provide written informed consent
3. No FFPE tumour material available for analysis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath